Nektar Therapeutics Files 2025 Proxy Statement
Ticker: NKTR · Form: DEF 14A · Filed: Apr 25, 2025 · CIK: 906709
Sentiment: neutral
Topics: proxy-statement, governance, annual-meeting
TL;DR
Nektar's proxy statement is out for the May 23rd shareholder meeting. Vote wisely.
AI Summary
Nektar Therapeutics filed its definitive proxy statement (DEF 14A) on April 25, 2025, for its annual meeting scheduled for May 23, 2025. The filing outlines the company's governance, executive compensation, and proposals to be voted on by shareholders. Key items likely include the election of directors and ratification of independent auditors.
Why It Matters
This filing provides shareholders with crucial information regarding company leadership, executive pay, and voting matters, enabling informed participation in corporate governance.
Risk Assessment
Risk Level: low — This is a routine annual filing (DEF 14A) and does not contain new material events or financial distress signals.
Key Players & Entities
- Nektar Therapeutics (company) — Registrant
- April 25, 2025 (date) — Filing Date
- May 23, 2025 (date) — Meeting Date
FAQ
What is the purpose of a DEF 14A filing?
A DEF 14A filing, also known as a definitive proxy statement, is filed by a company to solicit shareholder votes for its annual meeting or other matters requiring shareholder approval. It provides detailed information on executive compensation, director nominees, and proposals to be voted on.
When is Nektar Therapeutics' annual shareholder meeting scheduled?
Nektar Therapeutics' annual shareholder meeting is scheduled for May 23, 2025.
What is the filing date of this DEF 14A statement?
This definitive proxy statement was filed on April 25, 2025.
What is Nektar Therapeutics' Standard Industrial Classification (SIC) code?
Nektar Therapeutics' SIC code is 2834, which corresponds to Pharmaceutical Preparations.
What was Nektar Therapeutics' former company name?
Nektar Therapeutics was formerly known as INHALE THERAPEUTIC SYSTEMS INC, with a name change date of July 23, 1998. It was also previously named INHALE THERAPEUTIC SYSTEMS, with a name change date of March 3, 1994.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 25, 2025 regarding NEKTAR THERAPEUTICS (NKTR).